Clinical Trial Update: High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial update examining high-dose chemotherapy/radiotherapy followed by hematopoietic stem cell transplant for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Baylor College of Medicine | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED